Indy without Lilly, the 500?
An Indiana University prof thinks Indianapolis should anticipate a future without Indianapolis Motor Speedway, and a potentially
reduced Eli Lilly and Co.
An Indiana University prof thinks Indianapolis should anticipate a future without Indianapolis Motor Speedway, and a potentially
reduced Eli Lilly and Co.
New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that
could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.
Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health
care industry, reform is a reality that isn’t going to die.
The government has erected a high fence around a pot of $27 billion available to doctors and hospitals that successfully
computerize their patient records by next year, sparking complaints.
Analysts worry about dive in already paltry sales of new blood thinner Effient
But excluding special charges, Warsaw-based orthopedic implant maker grows profits 5 percent, easily beating expectations
of Wall
Street.
Anti-tobacco advocates worry cost-cutting move could seriously diminish state’s efforts to curb Hoosier tobacco use.
Republicans in the Legislature have joined their counterparts in 25 other states in trying to prevent key aspects of reform
from taking effect in Indiana.
The Indiana Osteopathic Association passed over a virtually certain $75 million in startup funding from Indiana Wesleyan University
to choose Marian University for its new osteopathic college.
Stephanie DeKemper believes everything in her adult life has prepared her to run SynCare LLC. She’s so
sure that she’s buying the company.
Doctors are pushing again to strengthen their hands in contract negotiations with health insurers, especially market leader
Anthem Blue Cross and Blue Shield.
Attorney General Greg Zoeller says he’ll look at the constitutionality of parts of the federal health care bill, including
the so-called Nebraska compromise.
The agency said the meeting was canceled “to allow time for the FDA to review new information” about a proposed new use for
the drug.
So far this year, 35 people have died in Indiana from swine flu.
Legislation set to come out of Washington will not change the most fundamental problems of the health
care system, leaving it up to states, cities and companies to figure out what to do about it.
Eli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart drug for sales personnel
to push.
Group presidents tell Indiana senators that the reform bill would expand dysfunctions of current health care systems.
Judge Sarah Evans Barker declared a Massachusetts woman in contempt of court for failing to remove her negative Internet
postings about an Indianapolis cosmetic surgeon.
Carmel firm using $12 million in venture capital for buying spree is now nation’s second-largest operator of sleep centers.